← Back to search

NGM Biopharmaceuticals Inc

NGM · NASDAQ

Pharmaceutical Preparation Manufacturing

NGM is a biopharmaceutical company focused on discovering and developing novel therapeutics based on scientific understanding of key biological pathways underlying liver and metabolic diseases, retinal diseases and cancer. The Company leverages its biology-centric drug discovery approach to uncover novel mechanisms of action and generate proprietary insights that enable it to move rapidly into proof-of-concept studies and deliver potential first-in-class medicines to patients. NGM aspires to operate one of the most productive research and development engines in the biopharmaceutical industry.

ESG Scores

Overall ESG
7.0
Environmental
5.6
Social
5.7
Governance
4.0

Gender Diversity

Female Directors0.4286%
Female Executives0.5%
Women in Workforce0.502%
CEO GenderMale